Accelmed

What is Accelmed?

Accelmed is an investment firm that primarily targets companies within the health technology sector, including those in medical devices, diagnostics, digital health, and technology-enabled healthcare services. Founded in 2009, initially as part of the Arkin family office, Accelmed has developed a prominent presence with its operations extending from New York to Israel, strategically positioning itself to support and nurture healthtech innovation across substantial markets. They specialize in providing Series A and Series B funding, which typically signifies Accelmed's commitment to companies at critical early to mid-stages of their development.

As a venture capital entity, Accelmed's investment thesis hinges on identifying high-potential healthtech enterprises and propelling them through strategic capital infusion, operational support, and leveraging an expansive network to accelerate growth trajectories. Accelmed's keen focus on the medical device sector, conjoined with a discerning eye for disruptive hospital services, positions the firm as a key player in the venture capital space. They are particularly adept at drawing on the robust technological infrastructure and entrepreneurial culture within Israel, coupled with the expansive market access and commercial prowess found in New York.

This bicoastal orientation not only serves as a testament to their global outlook but also enriches their portfolio companies with diverse expert perspectives and increased opportunities for commercialization and scaling.